Syria's principal public cancer hospital, a Damascus University hospital in Harasta on the edge of Damascus that takes patients from all over the country. In 2025 the IAEA announced a brachytherapy suite for women's cancers at a hospital it calls Al-Biruni Hospital in Damascus, which OnCo takes to be this one.
Al-Bairouni University Hospital, in Harasta in Rural Damascus, is described by researchers at Damascus University as the principal cancer centre in Syria, hosting patients from all over the country, most of them of low socioeconomic status; in their review of 2,367 breast cancer charts from January 2019 to May 2022, 58.3% of patients came from outside Damascus and its suburbs. A 2024 systematic review, citing a 2022 book chapter by Manachi and colleagues, reports that its registry recorded about 9,000 new cancers in 2020, that it sees over 60% of Syria's cancer patients and that it is the only treatment centre for thyroid cancer. WHO's 2020 HeRAMS report notes that Rural Damascus has one specialised cancer hospital and that cancer consultations were the highest of any non-communicable disease in public hospitals. The coordinates are an approximate Harasta point.
In June 2025 the IAEA wrote that, through its Rays of Hope initiative and with funding from the government of Italy, it was working with local teams to build Syria's first fully equipped brachytherapy suite at Al-Biruni Hospital in Damascus, which OnCo takes to be this hospital (the article does not give its full name or district), and training radiation oncologists, medical physicists and radiotherapy technologists while the machine was on its way. Studies from the hospital report late diagnosis: 19% of breast cancers were stage IV at diagnosis and fewer than 5% were found by screening mammography. A 2025 survey of 322 of its patients found that 98.8% had never heard of clinical trials.
Rebuilding cancer research in Syria will need transport support, trusted physicians and plain information, as well as sponsors.
Beyond ovarian cancer, the paper gives one of the few multi-hospital counts of all cancers diagnosed in Syria during the war years.
This is the most complete map of what is known about cancer care in Syria during the conflict, and it shows how little is measured: the authors report no national cancer registry from 2011 onwards.
Breast cancer in Syria is mostly found late and often diagnosed by surgery rather than a needle biopsy, which points to screening and diagnostic services as the first gaps to close.
Shares Ovarian cancer at three Syrian university hospitals, 2017 to 2021, Cancer and cancer services in Syria during the conflict: a systematic review, Ministry of Health, Syrian Arab Republic, Breast cancer (all types).
Shares Cancer and cancer services in Syria during the conflict: a systematic review, Ministry of Health, Syrian Arab Republic, Breast cancer (all types).
Shares Ministry of Health, Syrian Arab Republic, Breast cancer (all types).
Shares International Atomic Energy Agency: Rays of Hope, Cervical cancer, Breast cancer (all types).
Shares Ministry of Health, Syrian Arab Republic, Breast cancer (all types).
Shares International Atomic Energy Agency: Rays of Hope, Cervical cancer, Breast cancer (all types).
Shares International Atomic Energy Agency: Rays of Hope, Cervical cancer, Breast cancer (all types).
Shares Brachytherapy, International Atomic Energy Agency: Rays of Hope, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/